X0508 4 2024-09-01 false 0001568651 Oscar Health, Inc. OSCR 0001667819 Quane Alessandrea C. 75 VARICK STREET, 5TH FLOOR NEW YORK NY 10013 false true false false EVP, Chief Insurance Officer false Class A Common Stock 2024-09-01 4 M false 7016.00 A 258152.00 D Class A Common Stock 2024-09-01 4 M false 34380.00 A 292532.00 D Class A Common Stock 2024-09-01 4 M false 224503.00 A 517035.00 D Class A Common Stock 2024-09-01 4 M false 8652.00 A 525687.00 D Class A Common Stock 2024-09-03 4 S false 77181.00 17.99 D 448506.00 D Class A Common Stock 2024-09-04 4 S false 38740.00 17.46 D 409766.00 D Class A Common Stock 2024-09-04 4 S false 31616.00 17.85 D 378150.00 D Class A Common Stock 76857.00 I Alessandrea C Quane 2024 GRAT Restricted Stock Units 2024-09-01 4 M false 7016.00 0.00 D Class A Common Stock 7016.00 28063.00 D Restricted Stock Units 2024-09-01 4 M false 34380.00 0.00 D Class A Common Stock 34380.00 343796.00 D Restricted Stock Units 2024-09-01 4 M false 8652.00 0.00 D Class A Common Stock 8652.00 86525.00 D Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The Issuer previously granted the Reporting Person an award of 224,503 restricted stock units that vested on September 1, 2024, following the Talent & Compensation Committee's determination that the performance condition for the prior fiscal year had been achieved. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.66 to $18.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.63 to $17.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 to $18.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023. The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024. /s/ Melissa Curtin, Attorney-in-Fact 2024-09-04